Skip to Content
Emeritus Professor of Internal Medicine
- Hematology, Oncology and Blood and Marrow Transplantation
Primary Office: SE313 GHIowa City, IA 52242
Primary Office Phone: 319-356-8110
Lab: 5219 MERFIowa City, IA 52242
BS, Biochemistry, University of IllinoisMD, Rush Medical College, Rush UniversityPhD, Pharmacology, Graduate College, Rush University
Residency, University of ChicagoFellowship, Hematology/Oncology, University of Chicago
American Board of Clinical PharmacologyABIM. Subspeciality Board in Medical OncologyAmerican Board of Internal MedicineNational Board of Medical Examiners
Biosciences Graduate ProgramInterdisciplinary Graduate Program in Molecular and Cellular BiologyInterdisciplinary Graduate Program in Translational BiomedicineMedical Scientist Training Program
Dr. Hohl's research interests focus on understanding the interactions between mevalonic acid and cholesterol biosynthesis and the proliferation of acute myeloid leukemia cells. These studies investigate the relative affinities of various growth regulating proteins, such as RAS and KREV1, for the isoprene intermediates of the mevalonic acid to cholesterol biosynthetic pathway. His clinical interests involve evaluation of the potential role for pharmacologic inhibitors of this biosynthetic pathway in the treatment of various hematologic malignancies and solid tumors. Additionally, he has continued interest in studying how various erythrocyte enzymothathies predispose the human red blood cell to drug-induced oxidative damage.
Date Last Modified: 07/31/2014 -
Copyright © 2011 The University of Iowa. All Rights Reserved.